Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
Chinese Medical Journal ; (24): 1808-1812, 2018.
Article in English | WPRIM | ID: wpr-775140

ABSTRACT

Background@#The 47,XYY syndrome could result in fertility problems. However, seldom studies reported comprehensive researches on the embryonic development and pregnancy outcomes of these patients. This study aimed to evaluate the clinical outcomes of nonmosaic 47,XYY patients performed with fluorescent in situ hybridization (FISH) and preimplantation genetic diagnosis (PGD) treatment.@*Methods@#This was a retrospective study. Between January 2012 and May 2017, 51 infertile males with nonmosaic 47,XYY syndrome underwent FISH-PGD were included in the study. According to sex chromosomal FISH results, embryos were classified as normal signal, no nuclei fixed, no signal in fixed nuclei, suspensive signal, and abnormal signal groups, respectively. The incidence of each group, the fixation rate, and hybridization rate were calculated. Embryonic development and pregnancy outcomes were also analyzed. The measurement data were analyzed with Student's t-test. The comparison of categorical data was analyzed with the Chi-square test and Fisher's exact test when expected cell count was 0.05), and were significantly lower than the normal signal group (66.4%, P < 0.001). The clinical pregnancy rates of fresh and frozen embryos transferred cycles were 70.6% and 85.7%, respectively.@*Conclusions@#Among embryos with a clear diagnosis of sex chromosome, about one-fifth showed abnormal signals. Embryos with two sex chromosomal signals are more likely to develop into good-quality ones. The application of the PGD by FISH may help to improve the clinical outcome s.


Subject(s)
Female , Humans , In Situ Hybridization, Fluorescence , Infertility, Male , Genetics , Male , Pregnancy , Preimplantation Diagnosis , Retrospective Studies , Sex Chromosome Disorders , Diagnosis , Genetics , XYY Karyotype , Diagnosis , Genetics
2.
Article in Chinese | WPRIM | ID: wpr-691483

ABSTRACT

Objective:To observe the characteristics of the interstitial fluid (ISF) drainage in the Alzheimer's disease (AD) rats through magnetic resonance imaging (MRI) tracer gadolinium-diethylene triamine pentacetic acid (Gd-DTPA)spread in the brain extracellular space (ECS) and to discuss the role of aquaporin-4 (Aqp4) in the AD.Methods:Wild type SD rats (300-350 g) and Aqp4 gene knock out (Aqp4-/-) SD rats (300-350g) were divided into Sham group,AD group,Aqp4-/--Sham group and Aqp4-/--AD group.Sham group and Aqp4-/--Sham group were injected with saline by intraperitoneal each day for 6 weeks,and the AD group and Aqp4-/--AD group were injected with D-galactose by intraperitoneal each day for 6 weeks.MRI tracer Gd-DTPA (10 mmol/L,2 μL) was injected into the hippocampus of the rats.MRI scan was performed at the end of 0.5 h,1.5 h,1 h,2 h,and 3 h to observe the dynamic distribution of the Gd-DTPA in the hippocampus and the diffusion rate D *,clearance rate k'and half-life t1/2 measured.Results:The diffusion rate D* in Sham group was (2.66 ±0.36) × 10-6 mm2/s,the diffusion rate D* in AD group was (2.72 ±0.62) × 10-6 mm2/s,the diffusion rate D* in Aqp4-/--Sham group was (2.75 ± 0.47) × 10-6 mm2/s,the diffusion rate D* in Aqp4-/--AD group was (2.802 ±0.55) × 10-6 mm2/s,and there was no statistically significant difference in the four groups (One-Way ANOVA,P > 0.05).The clearance rate k'in Sham group was (4.57 ±0.14) ×10-4/s,the clearance rate k'in AD group was (3.68 ±0.22) × 10-4/s,the clearance rate k'in Aqp4-/--Sham group was (3.17 ±0.16) × 10-4/s,the clearance rate k'in Aqp4-/--AD group was (2.59 0.19) × 10-4/s,and there was significant difference in the four groups (OneWay ANOVA,P < 0.05).The half-life t1/2 in Sham group was (0.67 ± 0.12) h,the half-life t1/2 in AD group was (0.88 ±0.08) h,the half-life t1/2 in Aqp4-/--Sham group was (1.12 ±0.15) h,the halflife t1/2 in Aqp4-/--AD group was (1.58 ± 0.11) h,and there was significance difference in the four groups(one-way ANOVA,P < 0.05).Conclusion:The ISF drainage is slow after AD and the loss of Aqp4 in the AD makes the ISF drainage obviously slow down,Aqp4 plays an important role in AD to remove the metabolism of waste out of the brain.

3.
National Journal of Andrology ; (12): 919-921, 2010.
Article in Chinese | WPRIM | ID: wpr-266244

ABSTRACT

<p><b>OBJECTIVE</b>To explore the use of L-carnitine before percutaneous epididymal sperm aspiration-intracytoplasmic sperm injection (PESA-ICSI) in the treatment of obstructive azoospermia.</p><p><b>METHODS</b>Seventy-nine cases of obstructive azoospermia treated in our center from Sep 2008 to Aug 2009 were divided into an L-carnitine (n = 43) and a control group (n = 36), the former given oral L-carnitine at 1 g bid for 3 months before PESA-ICSI, while the latter left untreated. Comparisons were made between the two groups in the number of retrieved oocytes and fertilized oocytes as well as the number and rate of good embryos.</p><p><b>RESULTS</b>There were no significant differences between the two groups in the number of retrieved oocytes and fertilized oocytes. But the number and rate of good embryos were significantly higher in the L-carnitine than in the control group (P < 0.05).</p><p><b>CONCLUSION</b>Three-month oral medication of L-carnitine before PESA-ICSI can raise the number and rate of good embryos in obstructive azoospermia patients and therefore benefit the therapeutic outcome.</p>


Subject(s)
Adult , Azoospermia , Therapeutics , Carnitine , Therapeutic Uses , Epididymis , Humans , Male , Sperm Injections, Intracytoplasmic , Methods , Treatment Outcome
4.
Chinese Medical Journal ; (24): 414-419, 2008.
Article in English | WPRIM | ID: wpr-287722

ABSTRACT

<p><b>BACKGROUND</b>The mechanism of cerebral vasospasm following subarachnoid haemorrhage (SAH) is not understood. Here, we hypothesized that apoptosis of endothelial cells induced by p53 and its target gene em dash p53 upregulated modulator of apoptosis (PUMA) played an important role in development of cerebral vasospasm. We also observed the effects of a p53 inhibitor, pifithrin-alpha (PFT-alpha), on reducing the expression of p53 and PUMA, consequently decreasing the apoptosis of endothelial cells and alleviating cerebral vasospasm.</p><p><b>METHODS</b>Male Sprague-Dawley rats weighing 300-350 g were randomly divided into five groups: a control group (sham surgery), a SAH group, a SAH+dimethyl sulfoxide (DMSO) group, a SAH + PFT-alpha (0.2 mg/kg) group and a SAH + PFT-alpha (2.0 mg/kg) group. PFT-alpha was injected intraperitoneally immediately after SAH. Rats were sacrificed 24 hours after SAH. Western blot and immunohistochemical staining were used to detect the levels of p53, PUMA and caspase-3 protein. In addition, mortality and neurological scores were assessed for each group. Statistical significance was assured by analysis of variance performed in one way ANOVA followed by the Tukey test. The neurological and mortality scores were analyzed by Dunn's method and Fisher exact test, respectively.</p><p><b>RESULTS</b>After SAH, Western blot and immunohistochemical staining showed the levels of p53, PUMA and caspase-3 in the endothelial cells and the numbers of TdT mediated dUTP nick end labelling (TUNEL) positive endothelial cells were all significantly increased in the basilar arteries (P<0.05), but significantly reduced by PFT-alpha (P<0.05). These changes were accompanied by increasing diameters and declining wall thickness of basilar arteries (P<0.05), as well as reduced mortality and neurological deficits of the rats (P<0.05).</p><p><b>CONCLUSIONS</b>PFT-alpha could protect cerebral vessels from development of vasospasm and improve neurological outcome as well as reduce the mortality via suppressing apoptosis induced by p53 in the endothelial cells of cerebral vessels.</p>


Subject(s)
Animals , Apoptosis , Benzothiazoles , Pharmacology , Therapeutic Uses , Blotting, Western , Disease Models, Animal , Endothelial Cells , Pathology , Male , Rats , Rats, Sprague-Dawley , Subarachnoid Hemorrhage , Drug Therapy , Pathology , Toluene , Pharmacology , Therapeutic Uses , Tumor Suppressor Protein p53 , Physiology , Vasospasm, Intracranial
5.
Article in Chinese | WPRIM | ID: wpr-280010

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the sex chromosomes and the expression of insulin-like growth factor-II (IGF-II) on activated human unfertilized oocytes after intracytoplasmic sperm injection(ICSI) with calcium ionophore A23187 and puromycin.</p><p><b>METHODS</b>All 95 discarded oocyes that showed no evidence of fertilization at 16-18 h after in vitro maturation and intracytoplasmic sperm injection cycles (IVM-ICSI)/conventional ICSI were exposed to calcium ionophore A23187 (5 micromol/L) for 5 min and then were incubated with puromycin (10 microg/mL) for 4 h. After activation, the oocytes were cultured in vitro for 3-5 days. The sex chromosome analysis was performed by dual color fluorescence in situ hybridization. The expression of IGF-II on the activated embryos, normal embryos, and parthenotes was examined.</p><p><b>RESULTS</b>The combination of calcium ionophore A23187 with puromycin could activate the unfertilized oocytes 22 h after ICSI. The activated rate, cleavage rate, and quality of activated embryos of the IVM-ICSI group were similar to those of ICSI group, respectively. Sex chromosome analysis indicated that 8 male and 5 female embryos had been derived from two pronucleus and a second polar body. The expression of IGF-II on activated embryos and normal embryos was high and similar, which was much stronger than that of parthenotes.</p><p><b>CONCLUSION</b>The combination of calcium ionophore A23187 with puromycin could effectively activate unfertilized oocytes 22 h after ICSI. Moreover, the unfertilized oocytes activated by calcium ionophore A23187 and puromycin had normal sex chromosomes and expression of IGF-II like the normal embryos. These suggest that oocyte activation may be considered as a remedial measure in the presence of total or nearly total fertilization failure in ICSI.</p>


Subject(s)
Calcimycin , Pharmacology , Chromosomes, Human, X , Genetics , Chromosomes, Human, Y , Genetics , Female , Humans , In Situ Hybridization, Fluorescence , Insulin-Like Growth Factor II , Metabolism , Ionophores , Pharmacology , Oocytes , Cell Biology , Metabolism , Puromycin , Pharmacology , Sperm Injections, Intracytoplasmic , Methods
SELECTION OF CITATIONS
SEARCH DETAIL